2,3-Epoxynorbornene | CAS:278-74-0
2,3-Epoxynorbornene
- 名称:2,3-环氧降莰烷 | 2,3-Epoxynorbornene
- CAS号:278-74-0
- 别名:
- 分子式:C7H10O
- 分子量:110.15
- EINESC号:205-995-7
产品描述
物理化学性质
熔点 | 125-126 ºC** |
---|---|
沸点 | 170.2±8.0 ºC (760 Torr |
闪点 | 10.0±0.0 ºC, 计算值* |
密度 | 1.159±0.06 g/cm3 (20 º |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
p-Tolyl isocyanate derivatization for analysis of CWC-related polar degradation products by mass spectrometry.R Karthikraj et al.Analytical and bioanalytical chemistry, 406(21), 5093-5102 (2014-02-21)
A novel derivatization method for the determination of Fosfomycin in human plasma by liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometric detection via phase transfer catalyzed derivatization.Theodora A Papakondyli et al.Journal of chromatography. A, 1332, 1-7 (2014-02-11)
Strains of the toxic and bloom-forming Nodularia spumigena (cyanobacteria) can degrade methylphosphonate and release methane.Jonna E Teikari et al.The ISME journal, 12(6), 1619-1630 (2018-02-16)
[Acyclic nucleotide analogues based on phosphonic acids].E V Efimtseva et al.Bioorganicheskaia khimiia, 24(1), 16-20 (1998-04-29)
A simple LC-MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: application to a pilot pharmacokinetic study in humans.Suzanne L Parker et al.Journal of pharmaceutical and biomedical analysis, 105, 39-45 (2014-12-22)
Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling.Suzanne L Parker et al.Bioanalysis, 7(19), 2585-2595 (2015-10-17)
Development and validation of a LC-MS/MS method for quantitation of fosfomycin - Application to in vitro antimicrobial resistance study using hollow-fiber infection model.Adarsh Gandhi et al.Biomedical chromatography : BMC, 32(6), e4214-e4214 (2018-02-21)
Enhanced In Vitro Biocompatibility and Water Dispersibility of Magnetite and Cobalt Ferrite Nanoparticles Employed as ROS Formation Enhancer in Radiation Cancer Therapy.Stefanie Klein et al.Small (Weinheim an der Bergstrasse, Germany), 14(21), e1704111-e1704111 (2018-04-19)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!